iconmedicalimaging.comICON plc | Clinical Research Organisation (CRO) for Drug Development

Toggle navigation Services Services Our services span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs. Read More Services Adaptive Trials Clinical Research Services Consulting Early Phase Functional Services Provision Laboratories Language Services Medical Imaging Real World Intelligence Site & Patient Solutions Value Access Outcomes COVID-19 clinical operations Clinical trials during COVID-19. Decentralised & hybrid clinical solutions Bringing the clinical trial to the patient with innovation and in-home solutions. Sectors Sectors ICON provides its full range of clinical, consulting and commercial services across several industry sectors. Read More Sectors Biosimilars Biotech Government & Public Health Solutions Medical Device Pharmaceuticals The IVDR journey A roadmap to meet 2022 deadlines, while navigating pandemic disruptions. Government and Public Health Solutions Serving governments, multinational public health organisations, and global NGOs. Therapeutics Therapeutics We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators. Read More Therapeutics Cardiovascular Cell and Gene Therapies Central Nervous System Endocrine & Metabolic Disorders Genomics Infectious Diseases Internal Medicine & Immunology Medical Device Rare & Orphan Diseases Transplant Immunology Women's Health Oncology ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR-T therapies. Vaccines ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals. We are currently working on a number of COVID-19 vaccine trials. Innovation Innovation We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs. Read More Innovation FIRECREST Safety Reporting Solution One Search Evidence Platform FLEX ADVANTAGE Medical Imaging Technology NONMEM ICONIK PDx-POP PubsHub SIMS FIRECREST With travel restrictions due to COVID-19, FIRECREST helps deliver and manage remote training for investigators. Patient Engagement Platform Connecting patients with the right trial in the right location. Insights Insights BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations. Read More Insights Digital Disruption Patient Centricity Regulatory Intelligence Transforming Trials Value Based Healthcare Blog Videos Webinar Channel Coronavirus Observatory Aggregated news on COVID-19 clinical trials. Decentralised & hybrid clinical trials Patient focused research for better outcomes. News & Events News & Events ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards. Read More News & Events Press Releases In the News Events Mediakit Social Media Awards ICON supports Pfizer and BioNTech on COVID-19 vaccine trial Trial capabilities key to enabling agility and speed in global study involving 44,000 subjects. Webinar: Engaging physicians to support and increase clinical research activity 19 January, 2021 About ICON About ICON Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. Read More About ICON Company History ICON in Asia Pacific ICON in Latin America Leadership Quality Environmental, Social & Governance ICON is committed to making a positive impact on our people, environment and our community. ICON and You Partners making a difference. Careers Investors Investigators Patients Contact EN | 日本語 The evolution of HIV treatments From antiretroviral therapy to vaccines, where we are today and what’s next Read the whitepaper The IVDR journey A roadmap to meet 2022 deadlines, while navigating pandemic disruptions Read the whitepaper Agile Clinical Monitoring The flexibility to keep your trials on track Read the whitepaper Challenges and opportunities in traumatic brain injury clinical trials From identifying biomarkers to improving clinical trial efficiency Read the whitepaper Leveraging historical data for use in rare disease trials Understanding the Bayesian and Frequentist approaches. ICER’s impact on payer decision making Results of ICON’s third annual survey. Mitigating the impact of COVID-19 on cardiovascular trials Ensure patient safety and trial integrity during a global pandemic. Dynamics of patient centricity in clinical research Exploring the patient dynamic from different perspectives. Webinars Engaging physicians to support and increase clinical research activity 19 January, 2021. Register now. FT Digital Dialogues: Building resilience in pharma R&D by decentralising and digitising 3 February 2021. Register today. On-demand webinars Visit our webinar channel to access our library of archived webinars. Featured Services COVID-19 clinical operations Keeping your clinical trial on track in an evolving environment. Site & Patient Solutions Transforming recruitment through patient-centric trials and real-world, real-time data. Biotech ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation. Functional Resourcing From recruitment of a single clinical professional to managing entire global functions. Biosimilars ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars. Increasing Site and Patient Compliance FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance. ICON Insights 12 January 2021 Risk, vigilance, and remediation under IVDR The In Vitro Diagnostics Regulation (IVDR) — which goes into effect on May 26, 2022 — will have a lasting impact on the entire in vitro diagnostics (IVD) lifecycle, from development through clinical investigations and regulatory approval. Read more 08 January 2021 Managing COVID disruptions within IVDR timelines The COVID-19 pandemic has greatly impacted the IVD industry, including travel and social distancing restrictions, creating hassles and stalling NB designation processes. Read more 06 January 2021 Exploring the benefits of biotech partnerships The biotechnology sector is leading the way in developing innovative therapies that will address the unmet needs of many challenging diseases. Read more 04 January 2021 Cancer research post-COVID-19 The COVID-19 pandemic has been a catalyst for change in cancer research, forcing a shift towards remote monitoring, virtual arms and other uses of digital tools as global lockdowns reduce the ability of patients to go to clinics. Read more 09 December 2020 Harnessing digital health to advance traumatic brain injury clinical trials Advances in wearable technology have provided an effective tool to monitor outcomes and facilitate the delivery of interventions in patients across indications, especially those in need of rehabilitation interventions. Read more 03 December 2020 Bringing an invisible battle to the forefront: How to better design military-related TBI clinical trials A form of acquired brain injury that occurs when trauma causes damage to the brain, TBI has become increasingly apparent in military personnel. Read more 19 November 2020 C diff and COVID-19, is this a health risk that can be dealt with sooner than later? Today, with the development, widespread use, and poor prescribing practices of antibiotics over time, C diff infection rates have increased exponentially. Read more 18 November 2020 Agile clinical monitoring:...